Skip to main content
A scary good deal on trusted journalism
Get full digital access to globeandmail.com
$0.99
per week for 24 weeks SAVE OVER $140
OFFER ENDS OCTOBER 31
A scary good deal on trusted journalism
$0.99
per week
for 24 weeks
SAVE OVER $140
OFFER ENDS OCTOBER 31
// //

Victorian Premier Daniel Andrews, left, and Victorian COVID-19 Commander Jeroen Weima speak to the media during a press conference in Melbourne on July 27.

LUIS ASCUI/The Associated Press

Australia’s second-most populous city Melbourne will end its fifth lockdown on Tuesday with the Victoria state government declaring it had beaten an outbreak of the highly contagious COVID-19 delta variant for a second time.

The five-day lockdown across Victoria ends at 11:59 p.m., allowing schools, pubs and restaurants to reopen, Victoria Premier Daniel Andrews said. But people will not be allowed to have visitors in their homes for another two weeks.

“This lockdown ... sends a very clear message that we have seen off two delta outbreaks,” Andrews said. “I don’t think there’s a jurisdiction in the world that has been able to achieve that, and every Victorian should be proud of that.”

Story continues below advertisement

Sydney, Australia’s most populous city where the delta outbreak began in mid-June when a limousine driver was infected while transporting a U.S. air crew from the airport, remains in lockdown indefinitely after more than four weeks. The new outbreak has claimed 10 lives.

The New South Wales state government on Tuesday reported 172 new infections in the latest 24-hour period, a new daily record.

Victoria reported 10 new cases on Tuesday, but all had been in isolation while they were infectious.

It was the third consecutive day in which no new cases in Victoria had been in the community while infectious.

The South Australia government announced that the state’s week-long lockdown will end as planned on Wednesday after no new COVID-19 cases were recorded Tuesday.

Australian states are quick to lock down due to relatively small clusters because of the low vaccination coverage of the population. Only 16% of adults are fully vaccinated.

Australia’s immunization expert body, the Australian Technical Advisory Group on Immunisation, known as ATAGI, recommended on July 13 that adults under the age of 60 take Pfizer because of the increased risk of blood clotting in younger adults caused by the AstraZeneca vaccine. Pfizer and AstraZeneca are the only COVID-19 vaccines registered in Australia.

Story continues below advertisement

AstraZenca had been recommended for all adults until a 48-year-old died of blood clots in April, then for Australians over 50 until a 52-year-old died in May.

But with Sydney’s COVID-19 death toll rising, ATAGI on Saturday recommended adults as young as 18 in Sydney “should strongly consider getting vaccinated with any available vaccine” including AstraZeneca.

Australia has abundant stocks of locally-manufactured AstraZeneca, but imported Pfizer is in short supply. Most Australians under 40 have no access to Pfizer.

Because Australia has been relatively successful in containing COVID-19 outbreaks, many Australians are prepared to wait for months for Pfizer rather than risk AstraZeneca.

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies